Skip to main content
. 2017 Jun 5;285(1):44–52. doi: 10.1148/radiol.2017162033

Figure 1:

Figure 1:

BI-RADS audit flowchart. CDR, sensitivity, and specificity were calculated on the basis of positive or negative examination results. PPV2 and PPV3 were calculated on the basis of whether biopsy was recommended. Unresolved BI-RADS category 0 examinations were excluded from PPV calculations.